Taysha Gene Therapies, Inc. TSHA Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s interest paid?
- Taysha Gene Therapies, Inc. (TSHA) reported interest paid of $1.45M in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s interest paid changed year-over-year?
- Taysha Gene Therapies, Inc.'s interest paid increased by 11.8% year-over-year, from $1.29M to $1.45M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s interest paid?
- Over 3 years (2022 to 2025), Taysha Gene Therapies, Inc.'s interest paid has grown at a 24.8% compound annual growth rate (CAGR), from $2.78M to $5.4M.
- What does interest paid mean?
- Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.